03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Targoplanin* : | |
Type | Medicine Non Marketed |
Originator | Targocid 200mg |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | Hikma Italia SPA |
Manufacturing Type | G |
Origin | Italy |
ATC | J01XA02 |
Targoplanin* :
Targoplanin* :
Targoplanin* :
Targoplanin* :
Targoplanin* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Targoplanin* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abscess | Rare |
Agranulocytosis | Not known |
Anaphylactic reactions | Uncommon |
Anaphylactic shock | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Blood alkaline phosphatase increased | Uncommon |
Blood creatinine increased | Uncommon |
Bronchospasm | Uncommon |
Cephalea | Uncommon |
Chills | Not known |
Convulsion | Not known |
Deafness | Uncommon |
Dermatitis exfoliative | Not known |
Diarrhoea (Diarrhea) | Uncommon |
Dizziness | Uncommon |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Not known |
Eosinophilia | Uncommon |
Erythema | Common |
Erythema multiforme | Not known |
Hearing loss | Uncommon |
Injection site abscess | Not known |
Leucopenia (Leukopenia) | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Not known |
Nausea | Uncommon |
Neutropenia | Not known |
Pain | Common |
Phlebitis | Uncommon |
Platelet count decreased (Thrombocyte count decreased) | Not known |
Pruritus | Common |
Pyrexia | Common |
Red man syndrome | Rare |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Renal insufficiency | Not known |
Skin Eruption | Common |
Stevens-Johnson syndrome | Not known |
Superinfection | Not known |
Thrombophlebitis | Not known |
Tinnitus | Uncommon |
Transaminases increased | Uncommon |
Urticaria | Not known |
Vestibular toxicity | Uncommon |
Vomiting | Uncommon |
Targoplanin* :
NB : Products With Same Indication |
Different Units By MoH Code
Targoplanin* MoH 4057 :
Form | Powder for solution for injection |
Packaging | Bottle |
Package Size | Box of 1 |
Strength | 200mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 23857/07 |
Submission date | 01/01/2007 |
Registration Year | 2007 |
Archived Date | 02/03/2023 |
Price Comparison
● Country: | Italy | |
● Package Size: | 1UNITA | |
● Public Price: | 31.21 EUR | ( 3,023,499.96 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 31,21 EUR | ( 3,003,156.00 LBP ) |
● Pricing Date: | 15/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 14.21 JOD | ( 1,779,390.41 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 14,21 JOD | ( 1,753,094.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 25/05/2020 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 1 | |
● Public Price: | 68.45 SAR | ( 1,618,158.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 68,45 SAR | ( 1,607,520.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | France |
● Package Size: | 1 |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File